AIAlexandra L. Isaacson

Alexandra L. Isaacson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandra L. Isaacson has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Discrepancies with Final Diagnosis in Head and Neck Intraoperative Frozen Section

    by Scott Albright, Alexandra Isaacson, Robert Robinson

    Purpose: Creating a frozen section slide and crafting an interpretation is a multistep process with multiple possible points of failure. Head and neck frozen section pathology presents particular technical and diagnostic challenges. The aim of our study was to identify discrepancies between head/neck intraoperative and final diagnoses, determine the site of process failure, and assess the potential causes. Methods: Concordance data from head and neck intraoperative and final diagnoses (2020–2023) were queried from our LIS-embedded quality assurance system. Discrepancies were categorized as major and minor, with major defined as those that would have altered the surgical procedure. Results: We found 71 total discrepancies out of 1844 head and neck cases (3.9%). Major discrepancies accounted for 48/1844 (2.7%). Only major errors were considered for further study and were classified primarily into three categories: (1) inadequate gross sampling by the prosector, usually involving mucosal tissues of excised large specimens for evaluation of margins for dysplasia/carcinoma (14/48 cases; 29%), (2) insufficient sectioning into the block leaving undetected tissue unexamined (9/48 cases; 19%), and (3) interpretative errors (23/48 cases; 48%). The most common major interpretative errors involved the diagnosis of squamous dysplasia (9 cases), failure to identify minimally invasive squamous carcinoma (4 cases), failure to identify parathyroid and thyroid tissues (5 cases), and incorrect diagnoses of non-squamous neoplasms (5 cases). Two errors (4%) were ascribed to processing artifact issues in the frozen section. Conclusion: Half of diagnostic discrepancies occurred at steps prior to microscopic interpretation. Management of specimen grossing and tissue selection in large specimens, adequate block sectioning, and adherence to diagnostic criteria for difficult but common issues such as squamous dysplasia, minimally invasive carcinoma and thyroid/parathyroid morphology may help reduce intraoperative/final diagnosis discrepancies.

  • Open Access

    Development of a Cre-Inducible Rabl6a Transgenic Mouse Model That Enhances Sarcoma Growth In Vivo

    by Ellen M. Voigt, Alexandra L. Isaacson, Mariah R. Leidinger, James A. Goeken, Quinn Hanigan, Deng Fu Guo, Rachel M. Gasser, Makenna Eadie, Isabella Babor, Benjamin W. Darbro, et al.

    Background: Malignant peripheral nerve sheath tumors (MPNSTs) are deadly sarcomas that arise from Schwann cells and lack effective therapies. RABL6A is an oncogenic Rab-like GTPase whose expression is associated with worse survival in many human cancers. It is required for human MPNST cell survival, and its expression is dramatically increased in patient MPNSTs compared to benign precursor lesions. Methods: To model elevated expression of RABL6A in vivo, we developed transgenic mice expressing Cre-inducible Rabl6a. These Rabl6a-tg mice express the murine Rabl6a cDNA with a 5′ hemagglutinin [HA] epitope sequence downstream of a CMV enhancer and separated by a lox–stop–lox cassette. Double transgenic DhhCre; Rabl6a-tg mice were generated to achieve Schwann-cell specific Cre expression from the Desert hedgehog (Dhh) promoter. De novo MPNSTs were induced by CRISPR editing of Nf1, Ink4a, and Arf genes in the mouse sciatic nerve. Results: Cre-dependent expression of transgenic Rabl6a was verified at the mRNA and protein levels in Cre-positive mouse embryo fibroblasts and tissues. Increased Rabl6a expression in DhhCre; Rabl6a-tg mice had no effect on de novo MPNST initiation but significantly accelerated tumor progression relative to DhhCre control mice. The Rabl6a phenotype was associated with increased tumor angiogenesis but not proliferation. Interestingly, many MPNSTs in the DhhCre background exhibited varying levels of rhabdomyoblastic (RMB) features. That immature muscle cell phenotype is a hallmark of malignant Triton tumors, a rare histological variant of human MPNSTs associated with worse outcomes. Conclusions: These data provide direct evidence that Rabl6a is a functional driver of MPNSTs while establishing Rabl6a-tg mice as a suitable model for investigating Rabl6a’s role in other lethal RABL6A-high tumors.

  • Open Access

    Perineurioma‐like EMA ‐positive calvarial neoplasms: clinicopathological study of eight cases

    by Raheel Rizwan, Yingting Mok, Josephine K Dermawan, Alexandra Isaacson, Veronica Ulici, Scott E Kilpatrick, John D Reith, Gabrielle Yeaney, Hakan Ilaslan, Karen J Fritchie

    Background: Incidental skull lesions are increasingly detected due to the widespread use of brain imaging. We have encountered an unusual cohort of unclassifiable calvarial spindle cell lesions showing phenotypic overlap with perineurioma and meningioma, which we sought to further characterize. Material and methods: Cases of unclassifiable low‐grade spindle cell lesions arising in the calvarium were collected. Clinical, radiological and pathological findings were reviewed. All cases were uniformly stained for a panel of meningothelial and perineurial immunomarkers. Results: Eight cases were identified (6 females, 2 males; 51–81 years), arising in the parietal ( n = 4), frontal ( n = 3), parietal‐occipital ( n = 1) bones. Radiologically, the lesions appeared as lytic with non‐aggressive features, but progressive enlargement was documented in cases with serial imaging. Histologically, all cases were composed of uniform, bland spindle cells with elongated, tapered cytoplasm and inconspicuous nuclei arranged in short fascicles and whorls. Immunohistochemically, all cases were positive for EMA (8/8) and Collagen IV (3/3). The lesions showed consistent but limited staining for SSTR2a (2 cases, 6%–50%; 4 cases, 1%–5%). The lesional spindle cells were negative for PR (0/7), GLUT1 (0/6), S100 (0/6), CD34 (0/5), SOX10 (0/4) and claudin 1 (0/3). Follow‐up (available in 6 patients; range 6–61 months, median 15.5 months) showed no evidence of recurrence after curettage or excision. Conclusion: Perineurioma‐like, EMA‐positive calvarial neoplasms are a rare group of spindle cell tumours for which no local recurrence or distant metastasis has been documented to date, although they do show a propensity for progressive growth. Recognition of their distinctive clinicopathological and radiological features is important for accurate diagnostic classification and appropriate patient management.

  • Updates in keratin-positive mesenchymal neoplasia

    by Alexandra L. Isaacson, Karen J. Fritchie

  • Myxofibrosarcoma with epithelioid morphology: A clinicopathological study of 44 cases with emphasis on differential diagnosis

    by Alexandra L Isaacson, Ryan S Berry, Veronica Ulici, Susan M Armstrong, James Bena, Ivy John, Arivarasan Karunamurthy, Steven D Billings, Josephine K Dermawan, John Goldblum, et al.

    Aims: Epithelioid myxofibrosarcoma (eMFS) is an aggressive morphological variant associated with high rates of local recurrence and metastatic disease. The clinicopathological understanding of this disease is currently limited to a few small case‐series.Methods and results: We reviewed 44 cases of eMFS and classified them based on the presence of focal (< 50%) or diffuse (> 50%) epithelioid morphology and Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grade. The patients (28 males; 16 females) had a median age of 71 years (range = 14–90 years). The proximal extremity was the most common site (n = 21), followed by the trunk (n = 11), distal extremity (n = nine) and head/neck (n = two). Of cases with known depth of involvement (n = 41), 39 involved the subcutis, one was limited to the dermis and one limited to the skeletal muscle. Most cases (n = 34, 77%) demonstrated diffuse (> 50%) epithelioid morphology and were FNCLCC grade 3 (n = 29, 66%). Follow‐up data were available for 22 patients. Two developed local recurrence and 10 developed metastases, frequently to regional lymph nodes. All metastatic tumours had a primary lesion with diffuse epithelioid morphology (P = 0.09). There was no association between grade and recurrent or metastatic disease (P = 0.67 and 0.90, respectively). Three cases initially diagnosed as eMFS, one in the neck and two in the axilla, were found to have NRAS Q61R mutations and a high tumour mutation burden and/or ultraviolet (UV)‐light DNA mutational signature.Conclusions: These findings suggest that UV‐driven malignancies (including melanoma or sarcomatoid squamous cell carcinoma) may histologically mimic eMFS and should be considered in cases of eMFS presenting at atypical anatomical sites.


  • Intraosseous glomus tumours with NOTCH2/3 fusions: two cases presenting in the long bones with review of the literature

    by Alexandra L Isaacson, Veronica Ulici, Hakan Ilaslan, Karen J Fritchie, Josephine K Dermawan

  • Open Access

    PRC2 loss drives MPNST metastasis and matrix remodeling

    by Qierra R. Brockman, Amanda Scherer, Gavin R. McGivney, Wade R. Gutierrez, Andrew P. Voigt, Alexandra L. Isaacson, Emily A. Laverty, Grace Roughton, Vickie Knepper-Adrian, Benjamin Darbro, et al.

    The histone methyltransferase PRC2 plays a complex role in cancer. Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas with frequent loss-of-function mutations in PRC2 that are associated with poor outcome. Here, we identify a critical role for PRC2 loss in driving MPNST metastasis. PRC2-dependent metastatic phenotypes included increased collagen-dependent invasion, upregulation of matrix-remodeling enzymes, and elevated lung metastasis in orthotopic mouse models. Furthermore, clinical sample analysis determined that PRC2 loss correlated with metastatic disease, increased fibrosis, and decreased survival in patients with MPNSTs. These results may have broad implications for PRC2 function across multiple cancers and provide a strong rationale for investigating potential therapies targeting ECM-remodeling enzymes and tumor fibrosis to improve outcomes in patients with MPNSTs.


  • The Postmortem Features of Mucormycosis

    by Tracy S. Halvorson, Alexandra L. Isaacson, Bradley A. Ford, Dennis J. Firchau

    Mucormycosis is a rare and severe invasive fungal infection caused by ubiquitous fungi of the order Mucorales. Infection often occurs in immunocompromised hosts and includes cutaneous, pulmonary, gastrointestinal, rhinocerebral, and disseminated forms of disease. Although the clinical characteristics of mucormycosis are well established, infection can be difficult to diagnose antemortem, resulting in frequent postmortem diagnoses. Despite this, the gross appearance of mucormycosis at autopsy has not been well described. In the present report we illustrate the gross and histologic findings in four autopsy cases of mucormycosis, including one case of pulmonary disease and three cases of disseminated mucormycosis with cerebral, pulmonary, hepatic, renal, and gastrointestinal involvement. In all cases autopsy examination demonstrated characteristic hemorrhagic infarcts with a targetoid appearance in the affected organs. These findings are secondary to fungal angioinvasion with subsequent thrombosis and tissue necrosis. Mucormycosis should be suspected at autopsy when these characteristic infarcts are identified within the proper clinical context, and a high suspicion for atypical infections should be maintained postmortem in immunosuppressed patients.